Protalix Company Profile

Aggregated data from the web about Protalix

Company Name	Protalix
Website	https://protalix.com
Snippet	Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with its ProCellEx® plant cell-based expression system
Type	Public
Founded	1993
Founder	Yoseph Shaaltiel
Revenue	$11.51 million (2013)[1]
Website	protalix.com
Industry	Biotechnology
Products	Elelyso
Traded as	AMEX: PLXTASE: PLX
Key people	Shlomo Yanai (Interim Chairman)Moshe Manor (CEO)
Headquarters	Karmiel, Israel
Total assets	$113.33 million (2013)[1]
Number of employees	266 (2013)[1]

Protalix is part of the Israel company list

Protalix is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.